- Home
- SLRN vs SNDL Comparison
SLRN vs SNDL Comparison
Compare SLRN & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRN
- SNDL
- Stock Information
- Founded
- SLRN 2020
- SNDL 2006
- Country
- SLRN United States
- SNDL Canada
- Employees
- SLRN N/A
- SNDL N/A
- Industry
- SLRN Biotechnology: Pharmaceutical Preparations
- SNDL Pharmaceuticals and Biotechnology
- Sector
- SLRN Health Care
- SNDL Health Care
- Exchange
- SLRN Nasdaq
- SNDL Nasdaq
- Market Cap
- SLRN 485.6M
- SNDL 578.2M
- IPO Year
- SLRN 2023
- SNDL 2019
- Fundamental
- Price
- SLRN $4.37
- SNDL $1.99
- Analyst Decision
- SLRN Buy
- SNDL Buy
- Analyst Count
- SLRN 6
- SNDL 1
- Target Price
- SLRN $11.50
- SNDL $3.25
- AVG Volume (30 Days)
- SLRN 463.0K
- SNDL 2.7M
- Earning Date
- SLRN 11-13-2024
- SNDL 11-05-2024
- Dividend Yield
- SLRN N/A
- SNDL N/A
- EPS Growth
- SLRN N/A
- SNDL N/A
- EPS
- SLRN N/A
- SNDL N/A
- Revenue
- SLRN N/A
- SNDL $674,502,387.00
- Revenue This Year
- SLRN N/A
- SNDL $2.51
- Revenue Next Year
- SLRN N/A
- SNDL $4.54
- P/E Ratio
- SLRN N/A
- SNDL N/A
- Revenue Growth
- SLRN N/A
- SNDL 1.14
- 52 Week Low
- SLRN $3.36
- SNDL $1.30
- 52 Week High
- SLRN $8.89
- SNDL $2.93
- Technical
- Relative Strength Index (RSI)
- SLRN 31.17
- SNDL 46.51
- Support Level
- SLRN $4.29
- SNDL $1.92
- Resistance Level
- SLRN $6.19
- SNDL $1.99
- Average True Range (ATR)
- SLRN 0.45
- SNDL 0.09
- MACD
- SLRN -0.20
- SNDL -0.01
- Stochastic Oscillator
- SLRN 6.39
- SNDL 14.58
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.
About SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.